These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11106204)

  • 1. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole.
    Kiljander TO; Salomaa ER; Hietanen EK; Terho EO
    Eur Respir J; 2000 Oct; 16(4):633-8. PubMed ID: 11106204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult asthma and gastro-oesophageal reflux: the effects of omeprazole therapy on asthma.
    Teichtahl H; Kronborg IJ; Yeomans ND; Robinson P
    Aust N Z J Med; 1996 Oct; 26(5):671-6. PubMed ID: 8958363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal reflux in asthmatics: A double-blind, placebo-controlled crossover study with omeprazole.
    Kiljander TO; Salomaa ER; Hietanen EK; Terho EO
    Chest; 1999 Nov; 116(5):1257-64. PubMed ID: 10559084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asthma and gastro-oesophageal reflux: can the response to anti-reflux therapy be predicted?
    Kiljander T; Salomaa ER; Hietanen E; Helenius H; Liippo K; Terho EO
    Respir Med; 2001 May; 95(5):387-92. PubMed ID: 11392580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial.
    Dickman R; Emmons S; Cui H; Sewell J; Hernández D; Esquivel RF; Fass R
    Aliment Pharmacol Ther; 2005 Sep; 22(6):547-55. PubMed ID: 16167971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease.
    Johnsson F; Weywadt L; Solhaug JH; Hernqvist H; Bengtsson L
    Scand J Gastroenterol; 1998 Jan; 33(1):15-20. PubMed ID: 9489902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effects of high-dose omeprazole in patients with severe airway hyperresponsiveness and (a)symptomatic gastro-oesophageal reflux.
    Boeree MJ; Peters FT; Postma DS; Kleibeuker JH
    Eur Respir J; 1998 May; 11(5):1070-4. PubMed ID: 9648957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole in the treatment of asthmatics with nocturnal symptoms and gastro-oesophageal reflux: a placebo-controlled cross-over study.
    Ford GA; Oliver PS; Prior JS; Butland RJ; Wilkinson SP
    Postgrad Med J; 1994 May; 70(823):350-4. PubMed ID: 8016006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of omeprazole on gastro-oesophageal reflux and symptoms during strenuous exercise.
    Peters HP; De Kort AF; Van Krevelen H; Akkermans LM; Van Berge Henegouwen GP; Bol E; Mosterd WL; De Vries WR
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1015-22. PubMed ID: 10468675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
    Ours TM; Kavuru MS; Schilz RJ; Richter JE
    Am J Gastroenterol; 1999 Nov; 94(11):3131-8. PubMed ID: 10566703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y; Higuchi K; Nebiki H; Chono S; Uno H; Kitada K; Satoh H; Nakagawa K; Kobayashi K; Tominaga K; Watanabe T; Oshitani N; Arakawa T
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():10-8. PubMed ID: 15943841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
    Bardhan KD; Müller-Lissner S; Bigard MA; Bianchi Porro G; Ponce J; Hosie J; Scott M; Weir DG; Gillon KR; Peacock RA; Fulton C
    BMJ; 1999 Feb; 318(7182):502-7. PubMed ID: 10024259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
    Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
    Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstructive sleep apnoea is improved by a prolonged treatment of gastrooesophageal reflux with omeprazole.
    Bortolotti M; Gentilini L; Morselli C; Giovannini M
    Dig Liver Dis; 2006 Feb; 38(2):78-81. PubMed ID: 16256447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus".
    Watson RG; Tham TC; Johnston BT; McDougall NI
    Gut; 1997 May; 40(5):587-90. PubMed ID: 9203934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A pilot trial on the treatment of gastroesophageal reflux-related cough in infants].
    Adamko DJ; Majaesic CM; Skappak C; Jones AB
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 May; 14(5):321-7. PubMed ID: 22613099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern.
    Farup PG; Hovde O; Torp R; Wetterhus S
    Scand J Gastroenterol; 1999 Jun; 34(6):575-9. PubMed ID: 10440606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease.
    Lind T; Rydberg L; Kylebäck A; Jonsson A; Andersson T; Hasselgren G; Holmberg J; Röhss K
    Aliment Pharmacol Ther; 2000 Jul; 14(7):861-7. PubMed ID: 10886041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux.
    Moore DJ; Tao BS; Lines DR; Hirte C; Heddle ML; Davidson GP
    J Pediatr; 2003 Aug; 143(2):219-23. PubMed ID: 12970637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.